Roper Technologies, Inc. (ROP) Touches $334.42 High on Mar, 21; Shorts at Inflarx N.V. (IFRX) Raised By 17.35%

Roper Technologies, Inc. (NYSE:ROP) Logo

The stock of Roper Technologies, Inc. (NYSE:ROP) reached all time high today, Mar, 21 and still has $357.83 target or 7.00% above today’s $334.42 share price. This indicates more upside for the $34.65B company. This technical setup was reported by Barchart.com. If the $357.83 PT is reached, the company will be worth $2.43B more. The stock increased 1.12% or $3.7 during the last trading session, reaching $334.42. About 164,191 shares traded. Roper Technologies, Inc. (NYSE:ROP) has risen 19.98% since March 21, 2018 and is uptrending. It has outperformed by 15.61% the S&P500. Some Historical ROP News: 21/05/2018 – ROPER TECHNOLOGIES TO BUY POWERPLAN, LEADING PROVIDER OF; 21/05/2018 – THOMA BRAVO IN PACT TO SELL POWERPLAN TO ROPER TECHNOLOGIES; 21/05/2018 – PRESS RELEASE – THOMA BRAVO ENTERS INTO AGREEMENT TO SELL POWERPLAN TO ROPER TECHNOLOGIES; 20/04/2018 – ROPER TECHNOLOGIES BOOSTS FORECAST FOR 2018; 20/04/2018 – ROPER TECHNOLOGIES INC ROP.N FY2018 SHR VIEW $11.08 — THOMSON REUTERS l/B/E/S; 26/04/2018 – Reality Television Stars Tanner Tolbert and Jade Roper Tolbert Slim Down with Nutrisystem; 20/04/2018 – ROPER TECHNOLOGIES INC – 2018 GUIDANCE EXCLUDES IMPACT OF FUTURE ACQUISITIONS OR DIVESTITURES; 20/03/2018 – DAT Unveils Upgrades to Popular Load Board at Mid-America Trucking Show; 29/03/2018 – DAT Solutions Adds 5 TMS Integration Partners; 21/05/2018 – Roper announces $1.1 billion acquisition of PowerPlan, consolidating IT services for businesses

Inflarx N.V. (NASDAQ:IFRX) had an increase of 17.35% in short interest. IFRX’s SI was 443,000 shares in March as released by FINRA. Its up 17.35% from 377,500 shares previously. With 109,000 avg volume, 4 days are for Inflarx N.V. (NASDAQ:IFRX)’s short sellers to cover IFRX’s short positions. The SI to Inflarx N.V.’s float is 6.21%. The stock decreased 1.88% or $0.87 during the last trading session, reaching $45.29. About 172,437 shares traded or 51.40% up from the average. InflaRx N.V. (NASDAQ:IFRX) has risen 39.39% since March 21, 2018 and is uptrending. It has outperformed by 35.02% the S&P500. Some Historical IFRX News: 08/05/2018 – INFLARX N.V. REPORTS CLOSING OF PRIMARY, SECONDARY OFFERING; 29/03/2018 – lnflaRx Full Year 2017 Financial & Operating Results; 08/05/2018 – InflaRx N.V. Announces Closing of Primary and Secondary Offering of Common Shrs; 17/05/2018 – INFLARX NV – CASH POSITION APPROXIMATELY US$137 MLN (EUR 115 MLN) AS OF MARCH 31, 2018; 08/03/2018 InflaRx announces first patient enrolled in Phase IIb trial with lead candidate IFX-1 in Hidradenitis Suppurativa; 29/03/2018 – InflaRx FY Loss/Shr EUR2.6; 17/05/2018 – InflaRx 1Q Loss EUR10.3M; 17/05/2018 – InflaRx 1Q Loss/Shr EUR0.04; 08/03/2018 – INFLARX ANNOUNCES FIRST PATIENT ENROLLED IN PHASE llB TRIAL WITH LEAD CANDIDATE IFX-1 IN HIDRADENITIS SUPPURATIVA; 03/05/2018 – INFLARX PRIMARY, SECONDARY OFFERINGS PRICES AT $34.00 PER SHARE

Since November 26, 2018, it had 1 buying transaction, and 5 selling transactions for $5.78 million activity. JOHNSON ROBERT D sold $226,395 worth of stock. KNOWLING ROBERT E JR also sold $286,066 worth of Roper Technologies, Inc. (NYSE:ROP) on Monday, November 26. WALLMAN RICHARD F also bought $163,483 worth of Roper Technologies, Inc. (NYSE:ROP) shares. Crisci Robert also sold $1.23 million worth of Roper Technologies, Inc. (NYSE:ROP) on Tuesday, January 15. Shares for $1.54 million were sold by Conley Jason on Tuesday, February 12. Another trade for 9,000 shares valued at $2.66 million was sold by Stipancich John K.

Among 4 analysts covering Roper Technologies (NYSE:ROP), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Roper Technologies had 7 analyst reports since October 29, 2018 according to SRatingsIntel. The firm has “Equal-Weight” rating given on Monday, December 17 by Barclays Capital. The stock of Roper Technologies, Inc. (NYSE:ROP) earned “Equal-Weight” rating by Barclays Capital on Monday, October 29. Barclays Capital maintained Roper Technologies, Inc. (NYSE:ROP) on Wednesday, March 13 with “Hold” rating. The stock of Roper Technologies, Inc. (NYSE:ROP) has “Outperform” rating given on Monday, February 4 by Wells Fargo. The firm earned “Neutral” rating on Monday, February 4 by Robert W. Baird.

Investors sentiment decreased to 0.97 in 2018 Q4. Its down 0.19, from 1.16 in 2018Q3. It dived, as 41 investors sold Roper Technologies, Inc. shares while 225 reduced holdings. 68 funds opened positions while 191 raised stakes. 95.98 million shares or 4.75% more from 91.62 million shares in 2018Q3 were reported. Riverhead Mgmt Llc reported 3,171 shares. Tiaa Cref Mngmt Lc stated it has 0.25% of its portfolio in Roper Technologies, Inc. (NYSE:ROP). Robeco Institutional Asset Bv owns 18,435 shares or 0.02% of their US portfolio. Victory Cap Mgmt holds 0.21% or 309,861 shares. Bahl Gaynor owns 35,041 shares for 0.1% of their portfolio. Braun Stacey Incorporated reported 43,770 shares or 0.92% of all its holdings. Lakeview Ltd Company holds 0.33% in Roper Technologies, Inc. (NYSE:ROP) or 1,704 shares. Alexandria Capital Ltd Liability holds 6,053 shares or 0.26% of its portfolio. Asset Management stated it has 0.09% in Roper Technologies, Inc. (NYSE:ROP). Brown Brothers Harriman has 227 shares. Montecito Natl Bank & Tru, California-based fund reported 1,790 shares. Sumitomo Mitsui has invested 0.11% of its portfolio in Roper Technologies, Inc. (NYSE:ROP). Security Natl Tru, a West Virginia-based fund reported 6,828 shares. Usca Ria Ltd Liability Co holds 1,239 shares. Fmr Ltd Com has 885,005 shares for 0.03% of their portfolio.

Roper Technologies, Inc. designs and develops software, and engineered products and solutions. The company has market cap of $34.65 billion. It operates in four divisions: Medical & Scientific Imaging; RF Technology; Industrial Technology; and Energy Systems & Controls. It has a 36.95 P/E ratio. The firm offers diagnostic and laboratory software solutions; patient positioning devices and related software, 3-D measurement technology, and diagnostic and therapeutic disposable products; non-invasive instruments and video laryngoscopes; and a cloud financial analytics and performance software platform, as well as electron filters, charged couple devices, and complementary metal oxide semiconductor cameras, detectors, and related software.

More notable recent Roper Technologies, Inc. (NYSE:ROP) news were published by: Globenewswire.com which released: “Roper Technologies Announces Dividend NYSE:ROP – GlobeNewswire” on March 18, 2019, also Globenewswire.com with their article: “Roper Technologies Announces New Segment Structure NYSE:ROP – GlobeNewswire” published on March 04, 2019, Globenewswire.com published: “Roper Technologies to Acquire Foundry, Leading Provider of Complex Visualization Software Solutions – GlobeNewswire” on March 18, 2019. More interesting news about Roper Technologies, Inc. (NYSE:ROP) were released by: Globenewswire.com and their article: “Roper Technologies to Present at Raymond James Investor Conference – GlobeNewswire” published on February 26, 2019 as well as Globenewswire.com‘s news article titled: “Detailed Research: Economic Perspectives on Hecla Mining, Regency Centers, La-Z-Boy, EchoStar, Brown & Brown, and Roper Technologies — What Drives Growth in Today’s Competitive Landscape – GlobeNewswire” with publication date: February 28, 2019.

Analysts await Roper Technologies, Inc. (NYSE:ROP) to report earnings on April, 19. They expect $2.79 EPS, up 6.90% or $0.18 from last year’s $2.61 per share. ROP’s profit will be $289.07M for 29.97 P/E if the $2.79 EPS becomes a reality. After $3.22 actual EPS reported by Roper Technologies, Inc. for the previous quarter, Wall Street now forecasts -13.35% negative EPS growth.

More notable recent InflaRx N.V. (NASDAQ:IFRX) news were published by: Nasdaq.com which released: “WENDEL : 2018 Full-Year Results – Nasdaq” on March 21, 2019, also Nasdaq.com with their article: “Aid workers rush to rescue African cyclone victims amid mounting death toll – Nasdaq” published on March 21, 2019, Nasdaq.com published: “Mechel Reports the FY2018 Financial Results – Nasdaq” on March 21, 2019. More interesting news about InflaRx N.V. (NASDAQ:IFRX) were released by: Nasdaq.com and their article: “NoHo Partners Plc issues EUR 25 million hybrid bond – NASDAQ.com – Nasdaq” published on March 21, 2019 as well as Nasdaq.com‘s news article titled: “Ascendant Resources Reports Strong Fourth Quarter and Full Year 2018 Results – Nasdaq” with publication date: March 20, 2019.

InflaRx GmbH, a clinical-stage biopharmaceutical company, focuses on discovering and developing inhibitors using C5a technology in the United States. The company has market cap of $1.16 billion. The Company’s C5a is an inflammatory mediator involved in the enhancement of a variety of autoimmune and other inflammatory diseases. It currently has negative earnings. The firm is involved developing IFX-1, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; ANCA-associated vasculitis, a rare and life-threatening autoimmune disease; and other chronic/autoimmune diseases, as well as IFX-2 for the treatment of chronic inflammation and autoimmune diseases.

Roper Technologies, Inc. (NYSE:ROP) Institutional Positions Chart



Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *